Evidence map›Paper›PMID 33882063›Full record

ArticlePLoS genetics2021

A structural signature motif enlightens the origin and diversification of nuclear receptors.

Brice Beinsteiner, Gabriel V Markov, Stéphane Erb, Yassmine Chebaro, Alastair G McEwen, Sarah Cianférani, Vincent Laudet, Dino Moras, Isabelle M L Billas

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Hepatocyte Nuclear Factor 4 Alpha: A Key Regulator of Liver Disease Pathology and Haemostatic Disorders.Liver international : official journal of the International Association for the Study of the Liver · 2025
    Review
  2. Review
  3. Article
  4. Review
  5. Structural insights into the HNF4 biology.Frontiers in endocrinology · 2023
    Review
  6. Transcriptional control of energy metabolism by nuclear receptors.Nature reviews. Molecular cell biology · 2022
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Brice BeinsteinerIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.ORCID 0000-0002-4873-0550
Gabriel V MarkovSorbonne Université, CNRS, UMR 8227, Integrative Biology of Marine Models, (LBI2M, UMR8227), Station Biologique de Roscoff (SBR), Roscoff, France.ORCID 0000-0002-8566-7482
Stéphane ErbLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, Strasbourg, France.ORCID 0000-0001-7707-644X
Yassmine ChebaroIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.ORCID 0000-0002-5970-2117
Alastair G McEwenIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.ORCID 0000-0003-4484-3512
Sarah CianféraniLaboratoire de Spectrométrie de Masse BioOrganique, Université de Strasbourg, CNRS, IPHC UMR 7178, Strasbourg, France.
Vincent LaudetMarine Eco-Evo-Devo Unit. Okinawa Institute of Science and Technology, Onna-son, Okinawa, Japan.ORCID 0000-0003-4022-4175
Dino MorasIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.ORCID 0000-0001-7028-2320
Isabelle M L BillasIGBMC (Institute of Genetics and of Molecular and Cellular Biology), Illkirch, France.ORCID 0000-0003-2323-4208
Centre National de la Recherche Scientifique · FROkinawa Institute of Science and Technology Graduate University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear receptors are ligand-activated transcription factors that modulate gene regulatory networks from embryonic development to adult physiology and thus represent major targets for clinical interventions in many diseases. Most nuclear receptors function either as homodimers or as heterodimers. The dimerization is crucial for gene regulation by nuclear receptors, by extending the repertoire of binding sites in the promoters or the enhancers of target genes via combinatorial interactions. Here, we focused our attention on an unusual structural variation of the α-helix, called π-turn that is present in helix H7 of the ligand-binding domain of RXR and HNF4. By tracing back the complex evolutionary history of the π-turn, we demonstrate that it was present ancestrally and then independently lost in several nuclear receptor lineages. Importantly, the evolutionary history of the π-turn motif is parallel to the evolutionary diversification of the nuclear receptor dimerization ability from ancestral homodimers to derived heterodimers. We then carried out structural and biophysical analyses, in particular through point mutation studies of key RXR signature residues and showed that this motif plays a critical role in the network of interactions stabilizing homodimers. We further showed that the π-turn was instrumental in allowing a flexible heterodimeric interface of RXR in order to accommodate multiple interfaces with numerous partners and critical for the emergence of high affinity receptors. Altogether, our work allows to identify a functional role for the π-turn in oligomerization of nuclear receptors and reveals how this motif is linked to the emergence of a critical biological function. We conclude that the π-turn can be viewed as a structural exaptation that has contributed to enlarging the functional repertoire of nuclear receptors.

Indexed as

Amino Acid SequenceBinding SitesDimerizationEmbryonic DevelopmentGene Expression Regulation, DevelopmentalGene Regulatory NetworksHumansLigandsPromoter Regions, GeneticReceptors, Cytoplasmic and NuclearRetinoid X ReceptorsTranscription FactorsLigandsReceptors, Cytoplasmic and NuclearRetinoid X ReceptorsTranscription Factors

Identifiers

PMID33882063
PMCPMC8092661
OpenAlexW3153347342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.